Back to search
Diffuse Midline Glioma, H3 K27-Altered
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Diffuse Midline Glioma, H3 K27-Altered trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Diffuse Midline Glioma, H3 K27-Altered trials you may qualify forThis phase I/II trial evaluates the best dose, side effects and possible benefit of CBL0137 in treating patients with solid tumors, including central nervous sy…
The goal of this clinical research study is to learn about the safety and effects of M032 given directly into the tumor in children and adults with DMG and who…
This is a randomized, double-blind, placebo-controlled, parallel-group, international, Phase 3 study in patients with newly diagnosed H3 K27M-mutant diffuse gli…
The researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type…
This study is for people (children and adults) with a rare and aggressive brain tumor called H3K27-altered diffuse midline glioma (DMG) located in the pons, a d…
This is an open label, Phase 1b safety, dose-finding, brain tumor delivery, and pharmacokinetics study of intranasal NEO100 in patients with pediatric-type diff…